Multi-omics analysis identifies repurposing bortezomib in the treatment of kidney-, nervous system-, and hematological cancers by Peter Larsson, Maxim Olsson, Sithumini Sarathchandra, Anna Fäldt Beding, Eva Forssell-Aronsson, Anikó Kovács, Per Karlsson, Khalil Helou, Toshima Z. Parris

Get full text

Cancer stem cells are prevalent in the basal-like 2 and mesenchymal triple-negative breast cancer subtypes in vitro by Maxim Olsson, Peter Larsson, Peter Larsson, Junko Johansson, Junko Johansson, Vasu R. Sah, Vasu R. Sah, Toshima Z. Parris, Toshima Z. Parris

Get full text

Integrated transcriptomics- and structure-based drug repositioning identifies drugs with proteasome inhibitor properties by Peter Larsson, Maria Cristina De Rosa, Benedetta Righino, Maxim Olsson, Bogdan Iulius Florea, Eva Forssell-Aronsson, Anikó Kovács, Per Karlsson, Khalil Helou, Toshima Z. Parris

Get full text

Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer by Peter Larsson, Daniella Pettersson, Maxim Olsson, Sithumini Sarathchandra, Alexandra Abramsson, Henrik Zetterberg, Ella Ittner, Eva Forssell-Aronsson, Anikó Kovács, Per Karlsson, Khalil Helou, Toshima Z. Parris

Get full text